XML 81 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Cash Equivalents:    
Cost $ 1,531 $ 2,489
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,531 2,489
Available-for-Sale Investments:    
Cost 43 43
Gross Unrealized Gain 52 38
Gross Unrealized Loss 0 0
Fair Value 95 81
Total cash equivalents and available-for-sale investments, cost 1,574 2,532
Total cash equivalents and available-for-sale investments, gross unrealized gain 52 38
Total cash equivalents and available-for-sale investments, gross unrealized loss 0 0
Total cash equivalents and available-for-sale investments, fair value 1,626 2,570
Corporate debt    
Cash Equivalents:    
Cost 502 589
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 502 589
Government debt    
Cash Equivalents:    
Cost 1,029 1,900
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,029 1,900
Financial institution instruments    
Available-for-Sale Investments:    
Debt securities, cost 3 3
Debt securities, gross unrealized gain 0 0
Debt securities, gross unrealized loss 0 0
Debt securities, fair value 3 3
Marketable securities and mutual funds    
Available-for-Sale Investments:    
Equity securities, cost 40 40
Equity securities, gross unrealized gain 52 38
Equity securities, gross unrealized loss 0 0
Equity securities, fair value $ 92 $ 78